Is Paxlovid still recommended for COVID patients?
•
4 min read
In May 2023, the FDA granted full approval for Paxlovid for adults at high risk of severe COVID-19, confirming its role as a key therapeutic option. This decision has led many to question: **Is Paxlovid still recommended for COVID patients** in the evolving landscape of the virus?
